(Q40312042)

19 September 2017

title

Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma (English)

1 reference

19 September 2017

main subject

Merkel cell carcinoma

1 reference

9

Selma Ugurel

1 reference

19 September 2017

Roland Houben

1

1 reference

19 September 2017

Barbara Michel

2

1 reference

19 September 2017

Claudia S Vetter-Kauczok

3

1 reference

19 September 2017

Claudia Pföhler

4

1 reference

19 September 2017

Barbara Laetsch

5

1 reference

19 September 2017

Manfred D Wolter

6

1 reference

19 September 2017

J Helen Leonard

7

1 reference

19 September 2017

Uwe Trefzer

8

1 reference

19 September 2017

David Schrama

10

1 reference

19 September 2017

Juergen C Becker

11

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Journal of Investigative Dermatology

19 September 2017

published in

1 reference

19 September 2017

volume

126

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

1135-1142

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jid.5700170

19 September 2017

exact match

0 references

cites work

The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

1 reference

7 January 2021

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

The importance of being K-Ras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Identification of a novel inhibitor of mitogen-activated protein kinase kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Regulation of c-myc expression by Ras/Raf signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Characterisation of four Merkel cell carcinoma adherent cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Loss of heterozygosity of chromosome 13 in Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Signal transduction through MAP kinase cascades

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

The role of Raf kinases in development and growth of tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

RKIP downregulates B-Raf kinase activity in melanoma cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Merkel-cell carcinoma of the skin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Merkel cell carcinoma: in vitro and in vivo characteristics of a new cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Anticancer activity of farnesyltransferase and geranylgeranyltransferase I inhibitors: prospects for drug development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Expression of down stream molecules of RET (p-ERK, p-p38 MAPK, p-JNK and p-AKT) in papillary thyroid carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Mutation analysis of P73 and TP53 in Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Cancer genes and the pathways they control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

T1796A BRAF mutation is absent in Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700170

7 January 2021

Identifiers

DOI

10.1038/SJ.JID.5700170

1 reference

19 September 2017

1 reference